Virally directed cytosine deaminase/5-fluorocytosine gene therapy enhances radiation response in human cancer xenografts.

Virally directed cytosine deaminase/5-fluorocytosine gene therapy enhances radiation response in human cancer xenografts. Cancer Res. 1997 Oct 01; 57(19):4205-9.

View in: PubMed

subject areas

Adenoviruses, Human
Animals
Antimetabolites, Antineoplastic
Carcinoma, Squamous Cell
Combined Modality Therapy
Cytosine Deaminase
Female
Flucytosine
Genetic Therapy
Genetic Vectors
Humans
Laryngeal Neoplasms
Mice
Mice, Nude
Neoplasm Recurrence, Local
Neoplasm Transplantation
Neoplasms, Experimental
Nucleoside Deaminases
Radiation Tolerance
Radiation-Sensitizing Agents
Recombinant Fusion Proteins
Transfection
Transplantation, Heterologous

authors with profiles

Ralph R. Weichselbaum